亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

布洛芬價格 芬必得現貨 15687-27-1

 
 
單價 1.00 / kg對比
銷量 暫無
發貨 湖北宜昌市付款后24小時內
庫存 1kg起訂1kg
品牌 永諾
型號 15687-27-1
規格 紙板桶
過期 長期有效
更新 2016-12-19 11:46
 

宜昌永諾藥業有限公司

企業會員第13年
資料未認證
保證金未繳納
詳細說明

產品名稱:布洛芬
中文別名:異丁苯丙酸;異丁洛芬;對異丁苯丙酸;拔怒風;2-甲基-4-(2-甲基丙基)禁發 苯乙酸;2-(4-異丁基苯基)丙酸;芬必得;4-異丁基-Α-甲基禁發 苯乙酸;4-異丁基--α-甲基苯基乙酸
英文名稱:Ibuprofen
CAS編號:15687-27-1
分子式 :C13H18O2
分子量:206.2734
產品類別:解熱,止痛,抗炎類
 

外  觀:白色粉末
含  量:99%
用  途:神經系統用藥-抗偏頭痛藥
包  裝:25kg/桶
儲  存:常溫,通風,干燥環境下儲存。
 

用途:  具有抗炎、鎮痛、解熱作用。治療風濕和類風濕關節炎的療效稍遜于乙酰水楊酸和保
泰松。適用于治療風濕性關節炎、類風濕性關節炎、骨關節炎、強直性脊椎炎和神經炎等。該
品在1985年美國藥物銷售額排列順序中位列第十三。用作PG合成酶抑制劑,具有解熱鎮痛及消
炎作用                

============================================================
 

舉報收藏 0評論 0
更多>本企業其它產品
替莫唑胺價格  替莫唑銨現貨  85622-93-1 1,4-雄烯二酮(ADD)價格 897-06-3 7-酮基去氫表雄酮原粉 566-19-8 胞磷膽堿(原粉) 146929-33-1  胞膽堿價格 蝦青素(不同含量) 天然蝦青素  472-61-7 魚膠原蛋白原粉 金陽堿價格  新金陽堿  472-61-364 葡萄糖酸內酯現貨  葡萄糖酸內酯價格 90-80-2
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |